Fig. 5
From: Designing GLP-1 delivery: structural perspectives and formulation approaches for optimized therapy
A GLP-1, B Exenatide, C Lixisenatide, D Taspoglutide | E Liraglutide, F Semaglutide, G Tirzepatide | H Dulaglutide, I Albiglutide, J Efpeglenatide.
